Brief: Fusion Antibodies Agrees To Transfer Certain Background IP To Finn Therapeutics
30/03/2026 07:56
March 30 (Reuters) - Fusion Antibodies PLC FAB.L: ANTIBODY IP TRANSFER AGREEMENT AGREES TO TRANSFER CERTAIN BACKGROUND IP TO FINN THERAPEUTICS TO RECEIVE £250,000 ONE-OFF PAYMENT FOR IP TRANSFER TO RECOGNISE FULL IP TRANSFER FEE IN FY ENDING 31 MARCH 2026 ((Reuters.Briefs@thomsonreuters.com;;))